Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 9,451–9,475 of 27,380 studies, newest first · page 379 of 1096.

January 2022 18

  1. 2022-01-01

    Loneliness, Not Social Support, Is Associated with Cognitive Decline and Dementia Across Two Longitudinal Population-Based Cohorts

    ✓ Peer-reviewed Long-term cohort studies Journal of Alzheimer's disease : JAD

    Key finding: Poor social health is likely associated with cognitive decline and risk of dementia; however, studies show inconsistent results. +3 more findings

  2. 2022-01-01

    Etiology, risk factors, treatments and current status of Alzheimer's disease in Mexico

    ✓ Peer-reviewed Drug development Gaceta medica de Mexico

    Key finding: As regards diagnosis, advances in molecule detection techniques at femtomolar scales have allowed to distinguish between healthy and diseased subjects at relatively early stages, although there is still much to be done. +3 more findings

  3. 2022-01-01

    Making the Case for the Accelerated Withdrawal of Aducanumab

    ✓ Peer-reviewed Drug development Journal of Alzheimer's disease : JAD

    Key finding: Aducanumab has not demonstrated benefit to patients, failed to meet regulatory guidelines, and is likely to cause both individual and societal harm.

  4. 2022-01-01

    Limited Longitudinal Change in Self-reported Spatial Navigation Ability in Preclinical Alzheimer Disease

    ✓ Peer-reviewed Tau biomarkers Alzheimer disease and associated disorders

    Key finding: However, longitudinal change in self-reported spatial navigation ability in preclinical AD has yet to be examined. +3 more findings

  5. 2022-01-01

    Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy Bodies

    ✓ Peer-reviewed Tau biomarkers JAMA neurology

    Key finding: Alzheimer disease comorbid pathologic characteristics are common and are associated with more rapid cognitive decline in patients with dementia with Lewy bodies (DLB); therefore, it is anticipated that plasma p-tau concentrations may have utility in assessing cognitive impairment in individuals with this disorder. +3 more findings

  6. 2022-01-01
  7. 2022-01-01

    Human neural cell type-specific extracellular vesicle proteome defines disease-related molecules associated with activated astrocytes in Alzheimer's disease brain

    ✓ Peer-reviewed Mild cognitive impairment Journal of extracellular vesicles

    Key finding: A protein module enriched in astrocyte-specific EV markers was most significantly associated with the AD pathology and cognitive impairment, suggesting an important role in AD progression. +1 more finding

  8. 2022-01-01

    Advances in Deep Neuropathological Phenotyping of Alzheimer Disease: Past, Present, and Future

    ✓ Peer-reviewed Digital health tools Journal of neuropathology and experimental neurology

    Key finding: Such advancements include improving microscopy and staining techniques, refining diagnostic criteria for the disease, and increased appreciation for disease heterogeneity both in neuroanatomic location of abnormalities as well as overlap with other brain diseases; for example, Lewy body disease and vascular dementia. +4 more findings

  9. 2022-01-01

    Digital dementia in the internet generation: excessive screen time during brain development will increase the risk of Alzheimer's disease and related dementias in adulthood

    ✓ Peer-reviewed Digital health tools Journal of integrative neuroscience

    Key finding: Emerging evidence suggests that some of these effects are similar to those seen in adults with symptoms of mild cognitive impairment (MCI) in the early stages of dementia, including impaired concentration, orientation, acquisition of recent memories (anterograde amnesia), recall of past memories (retrograde amnesia), social functioning, and self-care. +3 more findings

  10. 2022-01-01

    Culture, Ethnicity, and Level of Education in Alzheimer's Disease

    ✓ Peer-reviewed Disparities Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

    Key finding: Studies have found significant effects of culture, preferred language, country of origin, race, and ethnicity on cognitive test performance, although the definition of those grouping terms varies across studies. +4 more findings

  11. 2022-01-01

    Omega-3 Supplementation for the Prevention of Cognitive Decline in Older Adults: Does It Depend on Homocysteine Levels?

    ✓ Peer-reviewed Treatments The journal of nutrition, health & aging

    Key finding: This study shows that Hcy levels could modify the association between red blood cell n-3 PUFA and executive function. +1 more finding

  12. 2022-01-01

    The Effect of Multidomain Interventions on Global Cognition, Symptoms of Depression and Apathy - A Pooled Analysis of Two Randomized Controlled Trials

    ✓ Peer-reviewed Treatments The journal of prevention of Alzheimer's disease

    Key finding: Cardiovascular risk factors and lifestyle factors are associated with an increased risk of cognitive decline and dementia in observational studies, and have been targeted by multidomain interventions. +4 more findings

  13. 2022-01-01
  14. 2022-01-01

    Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease

    ✓ Peer-reviewed Treatments JAMA neurology

    Key finding: Of 3285 included participants, the mean (SD) age was 70.4 (7.45) years; 1706 participants (52%) were female, 2661 (81%) had mild cognitive impairment due to Alzheimer disease, and 1777 (54%) used symptomatic medications for Alzheimer disease. +1 more finding

  15. 2022-01-01

    Amyloid PET: A Questionable Single Primary Surrogate Efficacy Measure on Alzheimer Immunotherapy Trials

    ✓ Peer-reviewed Biomarkers Journal of Alzheimer's disease : JAD

    Key finding: In vivo evidence indicates that PET quantification of amyloid deposition is distorted and misrepresents effects of anti-amyloid treatments due to lack of specificity of the PET imaging probe, effects of amyloid-related imaging abnormalities, spill-over from high white matter signals, and questionable quantification models.

  16. 2022-01-01

    Biomarkers of Age-Related Frailty and Frailty Related to Diseases: An Exploratory, Cross-Sectional Analysis from the MAPT Study

    ✓ Peer-reviewed Biomarkers The journal of nutrition, health & aging

    Key finding: Age-related frailty and disease-related frailty may represent different degrees of frailty severity on a biological level. +4 more findings

  17. 2022 no date recorded — placed by publication year

    Education, Occupational Complexity, and Incident Dementia: A COSMIC Collaborative Cohort Study

    ✓ Peer-reviewed Prevention and risk Journal of Alzheimer's Disease

    Key finding: Using datasets from a wide range of geographical regions, we found that both early life education and adulthood occupational complexity were independently predictive of dementia. +2 more findings

  18. 2022-01-01

    Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease

    ✓ Peer-reviewed Treatments The journal of prevention of Alzheimer's disease

    Key finding: Alzheimer's disease is a progressive, irreversible, and fatal disease for which accumulation of amyloid beta is thought to play a key role in pathogenesis. +3 more findings

December 2021 7

  1. 2021-12-31

    Causal association of cognitive reserve on Alzheimer's disease with putative sex difference

    ✓ Peer-reviewed Genetics Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: AD was associated with lower PRS for premorbid cognitive performance, intelligence, and educational attainment. +4 more findings

  2. 2021-12-31

    Reproducibility and replicability of high-frequency, in-home digital biomarkers in reducing sample sizes for clinical trials

    ✓ Peer-reviewed Cognitive tests and assessment Alzheimer's & dementia (New York, N. Y.)

    Key finding: For the reproducibility, identical P-values and slope estimates were found with both digital biomarkers and neuropsychological test measures between the previous and current studies. +2 more findings

  3. 2021-12-31

    Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseases

    ✓ Peer-reviewed Drug development RNA biology

    Key finding: RNA therapeutics comprise a diverse group of oligonucleotide-based drugs such as antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), and short hairpin RNAs (shRNAs) that can be designed to selectively interact with drug targets currently undruggable with small molecule-based drugs or monoclonal antibodies. +2 more findings

  4. 2021-12-31

    Possible association between PM2.5 and neurodegenerative diseases: A systematic review

    ✓ Peer-reviewed Inflammation and the immune system Environmental research

    Key finding: Selected studies have highlighted how PM 2.5 exposure can be associated with the onset of neurodegenerative diseases (AD, PD, MS, VaD). +2 more findings

  5. 2021-12-30

    Role of Phenolic Compounds in Human Disease: Current Knowledge and Future Prospects

    ✓ Peer-reviewed Risk factors Molecules (Basel, Switzerland)

    Key finding: Phenolic compounds can inhibit enzymes associated with the development of human diseases and have been used to treat various common human ailments, including hypertension, metabolic problems, incendiary infections, and neurodegenerative diseases. +1 more finding

  6. 2021-12-28

    Me & My Wishes: Concordance of End-of-Life Preferences between Residents with Dementia, Family, and Staff

    ✓ Peer-reviewed Health systems and care delivery Journal of palliative medicine

    Key finding: Thirty-six resident videos were shared with family (N = 50) and staff (N = 38) during care plan meetings. +4 more findings

  7. 2021-12-28

    TUBE Project: Transport-Derived Ultrafines and the Brain Effects

    ✓ Peer-reviewed Risk factors International journal of environmental research and public health

    Key finding: Moreover, the role of the semivolatile fraction of the emissions has been neglected. +4 more findings

Browse the library by subject, with the full score breakdown →